Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism

Several herbal plants improve medical conditions. Such plants contain many bioactive phytochemicals. Terpenoids (also called “isoprenoids”) constitute one of the largest families of natural products accounting for more than 40,000 individual compounds of both primary and secondary metabolisms. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications, for example, artemisinin and taxol as malaria and cancer medicines, respectively. Various terpenoids are contained in many plants for not only herbal use but also dietary use. In this paper, we describe several bioactive terpenoids contained in herbal or dietary plants, which can modulate the activities of ligand-dependent transcription factors, namely, peroxisome proliferator-activated receptors (PPARs). Because PPARs are dietary lipid sensors that control energy homeostasis, daily eating of these terpenoids might be useful for the management for obesity-induced metabolic disorders, such as type 2 diabetes, hyperlipidemia, insulin resistance, and cardiovascular diseases.

[1]  F. Luft,et al.  Farnesol Inhibits L-type Ca2+ Channels in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[2]  Johan Auwerx,et al.  Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Yu,et al.  Auraptene, a citrus fruit compound, regulates gene expression as a PPARα agonist in HepG2 hepatocytes , 2008 .

[4]  A. Qureshi,et al.  Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. , 1997, The Journal of nutrition.

[5]  S. Kitareewan,et al.  Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. , 1996, Molecular biology of the cell.

[6]  D. Giugliano,et al.  Are there specific treatments for the metabolic syndrome? , 2008, The American journal of clinical nutrition.

[7]  T. Kawada,et al.  Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation. , 2009, Biochemical and biophysical research communications.

[8]  R. Yu,et al.  Mesenteric Adipose Tissue‐Derived Monocyte Chemoattractant Protein‐1 Plays a Crucial Role in Adipose Tissue Macrophage Migration and Activation in Obese Mice , 2006, Obesity.

[9]  K. Miyashita,et al.  Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3‐L1 adipocytes and HepG2 hepatocytes , 2002 .

[10]  R. Yu,et al.  Abietic acid activates peroxisome proliferator‐activated receptor‐γ (PPARγ) in RAW264.7 macrophages and 3T3‐L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism , 2003, FEBS letters.

[11]  G. Giuliano,et al.  To dye or not to dye: biochemistry of annatto unveiled. , 2003, Trends in biotechnology.

[12]  C. Klinge,et al.  Estrogenic activity in white and red wine extracts. , 2003, Journal of agricultural and food chemistry.

[13]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[14]  S. Munné-Bosch,et al.  The Function of Tocopherols and Tocotrienols in Plants , 2002 .

[15]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[16]  S. Sen,et al.  Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol , 1997, Lipids.

[17]  W. Eisenreich,et al.  Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  V. Giguère,et al.  Orphan nuclear receptors: from gene to function. , 1999 .

[19]  J. Villalaín,et al.  The interaction of abietic acid with phospholipid membranes. , 1997, Biochimica et biophysica acta.

[20]  Jay D. Keasling,et al.  Biosynthesis and engineering of isoprenoid small molecules , 2007, Applied Microbiology and Biotechnology.

[21]  J. Auwerx,et al.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Camara,et al.  Biosynthesis of the Food and Cosmetic Plant Pigment Bixin (Annatto) , 2003, Science.

[23]  Philippe Lefebvre,et al.  Sorting out the roles of PPARα in energy metabolism and vascular homeostasis , 2006 .

[24]  H. Sahm,et al.  Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. , 1993, The Biochemical journal.

[25]  A. Reunanen,et al.  Food consumption and the incidence of type II diabetes mellitus , 2005, European Journal of Clinical Nutrition.

[26]  M. Gordon,et al.  Dietary supplementation with a natural carotenoid mixture decreases oxidative stress , 2003, European Journal of Clinical Nutrition.

[27]  R. Yu,et al.  Dietary regulation of nuclear receptors in obesity-related metabolic syndrome. , 2008, Asia Pacific journal of clinical nutrition.

[28]  J. Lehmann,et al.  An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.

[29]  R. Wanders,et al.  Phytanic acid: production from phytol, its breakdown and role in human disease , 2006, Cellular and Molecular Life Sciences.

[30]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[31]  S. White,et al.  RNAi-mediated chromatin silencing in fission yeast. , 2008, Current topics in microbiology and immunology.

[32]  T. Kawada,et al.  Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation. , 2008, Biochemical and biophysical research communications.

[33]  K. Umesono,et al.  Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice , 2003, Neuroscience Letters.

[34]  M. Rosenfeld,et al.  Biological roles and mechanistic actions of co-repressor complexes. , 2002, Journal of cell science.

[35]  J. Baxter Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease. , 1968, Journal of lipid research.

[36]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[37]  A. Miller,et al.  Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. , 1998, Alternative medicine review : a journal of clinical therapeutic.

[38]  M. Privalsky,et al.  The role of corepressors in transcriptional regulation by nuclear hormone receptors. , 2004, Annual review of physiology.

[39]  C. Glass Going nuclear in metabolic and cardiovascular disease. , 2006, The Journal of clinical investigation.

[40]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[41]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[42]  M. Nair,et al.  Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors. , 2005, Journal of agricultural and food chemistry.

[43]  E. Morrison,et al.  Hypoglycaemic activity of Bixa orellana extract in the dog. , 2008, Methods and findings in experimental and clinical pharmacology.

[44]  Robert H. White,et al.  Methanocaldococcus jannaschii Uses a Modified Mevalonate Pathway for Biosynthesis of Isopentenyl Diphosphate , 2006, Journal of bacteriology.

[45]  S. O’Rahilly,et al.  PPAR gamma and human metabolic disease. , 2006, The Journal of clinical investigation.

[46]  J. Sacchettini,et al.  Creating Isoprenoid Diversity , 1997, Science.

[47]  E. Swiezewska,et al.  Polyisoprenoids: structure, biosynthesis and function. , 2005, Progress in lipid research.

[48]  M. Lazar East meets West: an herbal tea finds a receptor. , 2004, The Journal of clinical investigation.

[49]  Frank J. Gonzalez,et al.  Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1* , 1999, The Journal of Biological Chemistry.

[50]  R. Yu,et al.  Dehydroabietic acid, a diterpene, improves diabetes and hyperlipidemia in obese diabetic KK‐Ay mice , 2009, BioFactors.

[51]  J Auwerx,et al.  Mechanism of action of fibrates on lipid and lipoprotein metabolism. , 1998, Circulation.

[52]  A. Fürholz,et al.  Crosstalk between cytosolic and plastidial pathways of isoprenoid biosynthesis in Arabidopsis thaliana , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Barish,et al.  PPARs and the complex journey to obesity , 2004, Nature Medicine.

[54]  Amir Gamliel,et al.  A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.

[55]  R. Evans,et al.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. , 2003, Cell.

[56]  G. Assmann,et al.  Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor α (PPARα) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice* , 1999, The Journal of Biological Chemistry.

[57]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[58]  S. Ferdinandusse,et al.  A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARalpha-dependent and -independent pathways. , 2005, Journal of lipid research.

[59]  C. Elson,et al.  Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. , 1995, The Journal of nutrition.

[60]  H. Ginsberg,et al.  Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. , 2005, Circulation research.

[61]  F. Gibberd,et al.  Diet and Refsum's disease. The determination of phytanic acid and phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsum's disease , 1993 .

[62]  T. Kawada,et al.  Phytol directly activates peroxisome proliferator-activated receptor α (PPARα) and regulates gene expression involved in lipid metabolism in PPARα-expressing HepG2 hepatocytes , 2005 .

[63]  H. Kataoka,et al.  Analysis of abietic acid and dehydroabietic acid in food samples by in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. , 2007, Journal of chromatography. A.

[64]  C. Elson,et al.  Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. , 1999, Journal of NutriLife.

[65]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[66]  M. A. Fernández,et al.  Anti‐inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea , 2001, The Journal of pharmacy and pharmacology.

[67]  William A. Boisvert,et al.  Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.

[68]  A. Qureshi,et al.  Impact of lemongrass oil, an essential oil, on serum cholesterol , 1989, Lipids.

[69]  S. O’Rahilly,et al.  PPARγ and human metabolic disease , 2006 .

[70]  R. Evans,et al.  Corepressors and nuclear hormone receptor function. , 2001, Current topics in microbiology and immunology.

[71]  M. Itoigawa,et al.  Antitumor-promoting activity of coumarins from citrus plants. , 2005, Planta medica.

[72]  J. Peñuelas,et al.  Isoprenoids: an evolutionary pool for photoprotection. , 2005, Trends in plant science.

[73]  I. Felzenszwalb,et al.  Norbixin ingestion did not induce any detectable DNA breakage in liver and kidney but caused a considerable impairment in plasma glucose levels of rats and mice. , 2002, The Journal of nutritional biochemistry.

[74]  R. Yu,et al.  Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. , 2008, Biochemical and biophysical research communications.

[75]  R. D. Simoni,et al.  Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels. , 1994, The Journal of biological chemistry.

[76]  F. Villarroya,et al.  The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation , 2002, International Journal of Obesity.

[77]  L. Antunes,et al.  Antioxidant action of bixin against cisplatin-induced chromosome aberrations and lipid peroxidation in rats. , 2001, Pharmacological research.

[78]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.